Skip to main content
. 2021 Jun 7;4(6):e1417. doi: 10.1002/cnr2.1417

TABLE 1.

Correlation between TDO2 expression and clinicopathologic features in bladder cancer

TDO2 expression, n (%) p‐value a
High Low
Histological grade Low grade 1 (20.0) 4 .157
High grade 24 (53.3) 21
T classification T1/2 3 (18.8) 13 .002
T3/4 22 (64.7) 12
N classification N0 13 (39.4) 20 .037
N1/2/3 12 (70.6) 5
M classification M0 21 (45.7) 25 .037
M1 4 (100) 0
Stage Stage I/II 2 (14.3) 12 .002
Stage III/IV 23 (63.9) 13
Recurrence Negative 9 (31.0) 20 .002
Positive 16 (76.2) 5
a

Chi‐square test.